Supporting your brain today for a better tomorrow. Order now!

Older female in meadow. Ombre circles to right of image.

Nutrition & Cognition Blog

Learn about Mild Cognitive Impairment

How to Make Sure the Cerefolin Brain Wellness® Product You’re Buying Is Real

Learn more about where you can buy authentic Cerefolin Brain Wellness® without a prescription.

For Alzheimer’s & Brain Awareness Month, Take Time to Understand & Protect Your Brain Health

June is Alzheimer’s & Brain Awareness Month—a time to spotlight the importance of brain health and support individuals facing cognitive challenges.

How do I know if I or a loved one have Mild Cognitive Impairment (MCI)?

Learn more about the signs of MCI and how you can help protect your brain health.

Disclaimers

Cerefolin Brain Wellness® is a medical food for the clinical dietary management of mild cognitive impairment with hyperhomocysteinemia and is specially formulated to meet the distinctive nutritional requirements for this condition. Use under medical supervision.

**Based on prescriptions written by neurologists as a proxy for recommendation. In a 2025 survey conducted by Zappi, 93% of consumers surveyed indicated a doctor prescribing a product is a recommendation.

§ Images don’t portray actual consumers and are for illustration purposes only.

|| Testimonials based on experience with CerefolinNAC®*.

* Cerefolin Brain Wellness®, formerly known and studied as CerefolinNAC®, is the same trusted and effective product that is now free from major allergens (milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, sesame and soy), dyes, and colorants.

† By submitting this information, I hereby give Alfasigma USA, Inc. authorization to release, reproduce, use or distribute information about me, in original or modified form, for promotional and educational purposes in all forms of media, including print, broadcast or Internet. This information may include my medical information if I choose to submit any. I understand my information may be shared with a third party working on Alfasigma USA, Inc.’s behalf for promotional or educational purposes. I also understand that I may be contacted by this third party or Alfasigma USA, Inc. for more information.

^†† This product should be taken under medical supervision, and you should consult your healthcare provider before taking this for mild cognitive impairment.

References

Shankle WR, et al. J Alzheimers Dis. 2016;54(3):1073-1084.
Shankle WR, et al. J Aging Res Clin Pract. 2013;2.
Hara J, et al. Nutr Health Aging. 2015;19.
Alfasigma USA, Inc. PLUS Program patient survey results. Data on file. 2012.
Alfasigma USA, Inc. Support data. Data on file. 2019-2024.
Chan A, Shea TB. J Nutr Health Aging. 2008;12(4):252-261.
de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD. Int J Geriatr Psychiatry. 2012;27(6):592-600.
Merrill E, Laughlin GA, Barrett-Connor E. Am J Epidemiol. 2005;162(7):644-653.
Reynolds EH. BMJ. 2000;320(7248):1512-1515.
de Jager CA, Refsum H, Smith AD. Neurobiol Aging. 2014;35(suppl 2):S35-S39.
Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. Curr Opin Pharmacol. 2007;7(4):355-359.
Kelly GS. Altern Med Rev. 2000;5(6):467-471.
Antoniades C, Shirodaria C, Warrick N, et al. Circulation. 2006;114(11):1193-1201.
Calderón-Ospina CA, Nava-Mesa MO. CNS Neurosci Ther. 2020;26(1):5-18.
Sah RP, et al. Ann Geriatr Med Res. 2023;27(4):370-380.
Rogers JD, Sanchez-Saffon A, Frol AB, Diaz-Arrastia R. Arch Neurol. 2003;60(1):59-64.
Smith AD, Refsum H. J Alzheimers Dis. 2016;54(4):1149-1166.
Seshadri S, Beiser A, Selhub J, et al. N Engl J Med. 2002;346(7):476-483.
Yao Y, Wang J, Wang J, et al. J Geriatr Cardiol. 2017;14(1):49-55.
Diaz-Arrastia R. Arch Neurol. 2000;57(10):1422-1428.
Keller AC, Kane MA, Heinze-Milne S, et al. J Appl Physiol. 2019;126(2):379-387.
Zhu Y, Liu J, Wang Y, et al. Climacteric. 2020;23(3):274-281.
Estrada DA, Ismail-Beigi F. Am J Hematol. 2001;67(3):221-227.
Luzzi S, D’Agostino V, Orlandi A, et al. Biomedicines. 2022;10(8):1892.
Diekman MJ, Anghelescu N, Endert E. Clin Endocrinol (Oxf). 2001;54(5):631-636.
Paknahad Z, Chitsaz A. Int J Prev Med. 2012;3(9):633-640.
DeSouza C, Keaney JF Jr. Drugs. 2002;62(12):1657-1670.
Myles PS, Leslie K, McNeil J, Forbes A, Chan MTV. Br J Anaesth. 2008;100(5):635-643.
Fallah S, Nouroozi V, Seifi M, Samadikuchaksaraei A. J Clin Lab Anal. 2012;26(5):360-365.
Lerman LO, Chade AR. Am J Physiol Heart Circ Physiol. 2022;322(4):H709-H720.
Troen AM, Shea-Budgell MA, Shukitt-Hale B, et al. Proc Natl Acad Sci U S A. 2008;105(34):12474-12479.
Hajj Mouhamed D, Ezzaher A, Neffati F, et al. Clin Chem Lab Med. 2011;49(6):987-993.
Smith AD, Smith SM, de Jager CA, et al. PLoS One. 2010;5(9):e12244.
Douaud G, Refsum H, de Jager CA, et al. Proc Natl Acad Sci U S A. 2013;110(23):9523-9528.
Xu M, Zhang Y, Liu Y, et al. Nutr Neurosci. 2023;26(6):417-430.
Sohouli MH, et al. Nutr Rev. 2023;82(6):726-737.

ALUSA-01273